Evidence map›Paper›PMID 22300770›Full record

ArticleAntiviral therapy2012

Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects.

Emmanouil Papasavvas, Priscilla Hsue, Griffin Reynolds, Maxwell Pistilli, Aidan Hancock, Jeffrey N Martin, Steven G Deeks, Luis J Montaner

Open access · greenAbstract read
In one paragraph

Article in Antiviral therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The CD133Frontiers in cellular and infection microbiology · 2020
    Article
  5. Article
  6. Article
  7. HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.Journal of the American College of Cardiology · 2017
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Emmanouil PapasavvasThe Wistar Institute, Philadelphia, PA, USA.
Priscilla Hsue
Griffin Reynolds
Maxwell Pistilli
Aidan Hancock
Jeffrey N Martin
Steven G Deeks
Luis J Montaner
The Wistar Institute · USUniversity of California, San Francisco · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV InfectionR01HL095130 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSUE, PRISCILLA Y. · 2008 to 2012
$5.1M
UCSF-GIVI CENTER FOR AIDS RESEARCHP30MH059037 · NIMH · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI FEINBERG, MARK A · 1998 to 2001
$4.9M
HIV Therapy &Interruption RCT in Resource Poor ClinicU01AI051986 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J · 2005 to 2010
$3.0M
Antiviral activity of Peg-IFN alpha in chronic HIV-1U01AI065279 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J · 2005 to 2009
$2.8M
IMMUNE AND VIRAL OUTCOMES OF HIV-1 THERAPY INTERRUPTIONR01AI048398 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J. · 2000 to 2003
$2.4M
Preventing the Establishment of Enfuvirtide-resistance in the Latent ReservoirK24AI069994 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2007 to 2016
$1.5M
HIV Therapy &Interruption RCT in Resource Poor ClinicR01AI051986 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J. · 2003 to 2004
$983k
Pathogenesis of Atherosclerosis in HIV Patients on HAARTK23AI066885 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSUE, PRISCILLA Y. · 2005 to 2009
$609k
NCRR NIH HHS UL1 RR024131NCRR NIH HHS UL1 RR024131-01NHLBI NIH HHS 5R01HL095130NHLBI NIH HHS R01 HL095130NIAID NIH HHS 5K23AI066885NIAID NIH HHS AI051986NIAID NIH HHS AI 065279NIAID NIH HHS AI48398NIAID NIH HHS K23 AI066885NIAID NIH HHS K24 AI069994NIAID NIH HHS P30 AI027763NIAID NIH HHS P30 AI27763NIAID NIH HHS R01 AI048398NIAID NIH HHS R01 AI051986NIAID NIH HHS U01 AI051986NIAID NIH HHS U01 AI065279NIMH NIH HHS P30 MH059037NIMH NIH HHS P30 MH062246NIMH NIH HHS P30 MH59037NIMH NIH HHS P30 MH62246
6 · The paper itself

Abstract

backgroundEndothelial progenitor cells (EPCs) are involved in the endothelium repair. Low circulating EPC levels are predictive of cardiovascular events in HIV-negative subjects. The impact of HIV infection on EPCs, and the role of EPCs in HIV-associated cardiovascular disease, is not known. We hypothesized that circulating EPCs would be inversely associated with carotid artery intima-media thickness (c-IMT) changes in HIV-infected subjects.

methodsEPCs (CD34(+)/KDR(+), CD133(+)/KDR(+) and CD34(+)/CD133(+)/KDR(+)) were defined retrospectively by flow cytometry in cryopreserved peripheral blood mononuclear cells collected longitudinally from 66 chronic HIV-infected subjects and cross-sectionally from 50 at-risk HIV-negative subjects. The HIV-infected subjects participated in the Study of the Consequences of the Protease Inhibitor Era (SCOPE) cohort, were receiving antiretroviral therapy (59/66) and had two sequential measurements of c-IMT 1 year apart. Two distinct groups of HIV-infected subjects were identified a priori: rapid c-IMT progressors (subjects with rapid c-IMT progression, n=13, Δc-IMT>0.2 mm) and slow c-IMT progressors (subjects with slow or no c-IMT progression, n=53, Δc-IMT<0.2 mm).

resultsAlthough cryopreservation reduced sensitivity of detection, EPC frequency in HIV-infected subjects was still significantly higher compared to at-risk HIV-negative subjects (CD34(+)/KDR(+); P=0.01) and correlated positively with CD4(+) T-cell count (CD34(+)/KDR(+), r=0.27; P=0.03). No association was found between the change of EPC frequencies over time (ΔEPC) and Δc-IMT or between EPC frequencies and c-IMT or Δc-IMT.

conclusionsThe lack of an association between EPCs and c-IMT in our cohort does not support HIV-associated reductions in EPC frequency as a cause of accelerated atherosclerosis.

Indexed as

Carotid Intima-Media ThicknessAntigens, CD34AtherosclerosisCarotid ArteriesChronic DiseaseDisease ProgressionEndothelial CellsEndothelium, VascularFemaleFlow CytometryHIV InfectionsHumansMaleMiddle AgedStem CellsTunica IntimaAntigens, CD34

Identifiers

PMID22300770
PMCPMC3362125
OpenAlexW2044876820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.